Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 4/5
Dr Lal PathLabs Ltd (DLPL IN)
Watchlist
Contact IR
80
Analysis
Health Care
•
India
Dr. Lal PathLabs Limited operates clinical laboratories. The Company offers medical diagnostic, cardiology, radiology, pathology and imaging, health checkup, blood test, and customer care services. Dr. Lal PathLabs conducts its business in India.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Agilus Diagnostics Limited
•
08 Feb 2024 02:16
Agilus Diagnostics Limited Pre-IPO - Still Recovering from COVID
Agilus Diagnostics Limited (SRLL IN) is looking to raise around US$200m in its upcoming India IPO. In this note, we talk about the company's past...
Sumeet Singh
Follow
610 Views
Share
bullish
•
Prodia
•
29 Dec 2023 12:00
Prodia (PRDA IJ) - Diagnosing a Return to Healthy Profits
Prodia (PRDA IJ) is significantly cheaper than its Indian comparables, trading on half the valuation, despite being a high-quality player tapping...
Angus Mackintosh
Follow
681 Views
Share
bullish
•
SBFC Finance Limited
•
07 Nov 2023 12:08
[Week 10] Namaste India 🙏 | Earnings Edition - Final Part
This Insight is the final dedicated earnings edition, providing a consolidated view of all earnings tracked so far. At the end we also provide...
Pranav Bhavsar
Follow
353 Views
Share
bullish
•
Agilus Diagnostics Limited
•
17 Oct 2023 15:39
Agilus Diagnostics Pre-IPO: Large Scale of Operation and Favorable Sector Demand To Drive Growth
Agilus Diagnostics is the largest diagnostics service provider in India. With pan-India network and comprehensive test menu, the company is poised...
Tina Banerjee
Follow
724 Views
Share
bullish
•
Prodia
•
30 Sep 2023 13:23
Prodia (PRDA IJ) - Going Digital with Precision
Prodia (PRDA IJ) remains one of our top healthcare picks in Indonesia, with rising health consciousness driving higher demand for testing....
Angus Mackintosh
Follow
756 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x